Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −241,690−100.0% | Sold out | Holders |
| Q2 2023 | 241,690 | $22.0M | 7.6% | −42,000−14.8% | Reduced | Holders |
| Q1 2023 | 283,690 | $18.7M | 7.1% | −51,200−15.3% | Reduced | Holders |
| Q4 2022 | 334,890 | $17.3M | 5.6% | +68,800+25.9% | Added | Holders |
| Q3 2022 | 266,090 | $18.2M | 6.0% | −52,310−16.4% | Reduced | Holders |
| Q2 2022 | 318,400 | $14.4M | 5.0% | +318,400 | New | Holders |